Novalent Signs Distribution Agreement with Force Shield

Novālent Biotech, Inc (‘Novālent’), a US biotechnology engineering firm, is pleased to announce that they have signed a distribution agreement with Tennessee based Force Shield.

Force Shield distributes a wide array of products to the Armed Forces and Government channels around the world, including high-tech materials that protect vehicle occupants from mine and other explosive blasts, and flexible body armor that stops bullet penetration.

“We are very excited to sign a distribution agreement with Force Shield to drive sales in the Government and Armed Forces channels. Both are emerging channels for Novalent and our technology and this partnership with Force Shield will provide an excellent opportunity to further excel sales and provide a value-added product portfolio to these end-users.”  says Vice President of Sales Brian Morabito.

Vinnie Cooper, CEO of Force Shield, stated, “Force Shield has a long history of providing specialty materials that protect our fine men and women from bullets and blasts. By partnering with Novalent we are able to extend that protection from bullets to biocides”

This partnership with Force Shield will give Novalent® a strong distribution partner that serves the Armed Forces and Government channels worldwide. The Novalent team is excited to begin this partnership with Force Shield.


About Novalent®

Novalent® is a leading US biotechnology engineering firm which has pioneered the development of long-lasting technology to protect against bacteria. Novalent® technology is based on a patented, non-toxic monomolecular layer that continuously inhibits microbial growth for up to 90 days on surfaces after application. Novalent is privately backed and is headquartered in Greensboro, North Carolina. For more information on Novalent®, visit